You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

ISOSORBIDE DINITRATE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Isosorbide Dinitrate, and what generic alternatives are available?

Isosorbide Dinitrate is a drug marketed by Impax Labs Inc, Sun Pharm Inds Inc, Ani Pharms, Endo Operations, Hikma Intl Pharms, Rubicon, Sandoz, Sun Pharm Industries, Superpharm, Watson Labs, Zydus Lifesciences, Watson Labs Teva, I3 Pharms, and Riconpharma Llc. and is included in thirty-six NDAs.

The generic ingredient in ISOSORBIDE DINITRATE is hydralazine hydrochloride; isosorbide dinitrate. There are twenty-one drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the hydralazine hydrochloride; isosorbide dinitrate profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for ISOSORBIDE DINITRATE?
  • What are the global sales for ISOSORBIDE DINITRATE?
  • What is Average Wholesale Price for ISOSORBIDE DINITRATE?
Summary for ISOSORBIDE DINITRATE
Drug patent expirations by year for ISOSORBIDE DINITRATE
Drug Prices for ISOSORBIDE DINITRATE

See drug prices for ISOSORBIDE DINITRATE

Recent Clinical Trials for ISOSORBIDE DINITRATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Copenhagen University Hospital, HvidovrePhase 4
Johannes GrandPhase 4
Bispebjerg HospitalPhase 4

See all ISOSORBIDE DINITRATE clinical trials

Pharmacology for ISOSORBIDE DINITRATE
Drug ClassNitrate Vasodilator
Physiological EffectVasodilation
Medical Subject Heading (MeSH) Categories for ISOSORBIDE DINITRATE

US Patents and Regulatory Information for ISOSORBIDE DINITRATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs ISOSORBIDE DINITRATE isosorbide dinitrate TABLET;SUBLINGUAL 086033-001 Feb 26, 1988 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Zydus Lifesciences ISOSORBIDE DINITRATE isosorbide dinitrate TABLET;ORAL 213057-004 Nov 20, 2019 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Watson Labs ISOSORBIDE DINITRATE isosorbide dinitrate TABLET;ORAL 086034-001 Jan 6, 1988 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Zydus Lifesciences ISOSORBIDE DINITRATE isosorbide dinitrate TABLET;ORAL 213057-005 Nov 20, 2019 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.